Pressroom | Career | Contact | Imprint | Sitemap

Home

About Nano2Life

Research

Technology Driven

Application Driven

Drug Delivery and Theranostics

Cancer Related Nanodiagnostics

Converging Technologies (NBIC)

Cell Biology

In Vitro Toxicology

Intersection Projects

Activities

About NanoBio

e-Learning

Databases

Newsletter
Subscribe to our Newsletter and get Information about Nano2Life:

Search

Login
[Login to members area]
[Password forgotten?]


One of 23 N2L Partners:


Converging Technologies (NBIC)

Providing an Intellectual Breakthrough



Animal cell (fibroblast) on nanopatterned substrate
Converging technologies is an emerging multi-disciplinary research approach that is expected to provide an intellectual breakthrough in understanding how complex systems (e.g. the brain) interact with the environment and produce coherent behaviour. It is based on transforming tools and know-how among various research fields and technologies, such as NBIC (Nano Bio Info Cogno). Such an intellectual breakthrough requires deep comprehension of biology, biotechnology and biomedicine, physics and mathematics, computer science, information technology, nano-science and nanotechnology cognitive sciences and neuroscience, as well as wide range of engineering, and special attention to ethics, philosophy of science, etc.

 

The focus of this working group is an application driven research mainly in the neurodegenerative medicine area, while creating a research infrastructure at the confluence of NBIC domains. The development of transforming tools at interdisciplinary sectors could be applied to the understanding of specific systems at the nanoscale level, e.g. brain multilevel functioning, cognitive sciences, behavioural sciences, brain repair, early detection of degenerative disease and treatment development, etc.

Cooperation with Other Research Groups

Cooperation with other SRPA and SRPT groups is needed, especially in the fields of engineers, biologists, imaging, bio informatics and cognitive sciences. Three intersection projects have already been launched: optic nerve regeneration (in collaboration with Prof. Ari Barzilai, Tel Aviv University, Israel), investigation of mechanisms of dopaminergic neurodegeneration and neuroprotection (lead by Prof. Maria Klapa, FORTH, Greece), and the rehabilitation of cerebellar functionality by nano-interfaced model chip (lead by Prof. Matti Mintz, Tel Aviv University, Israel).




Contact
Dr. Mira Marcus-Kalish
Tel Aviv University
miram[at]post.tau.ac.il




NanoBio-News
Multifunctional pharmaceutical nanocarriers
Carriers are needed for a number of reasons in drug delivery, e.g. to protect the drug from the body, to protect the body from the drug and to adjust the pharmacokinetics, i.e. distribution and clearance, of the drug. [more]
Nanotechnologies in the Food Sector
The UK’s House of Lords Science and Technology Committee today published the findings of their 2009 inquiry into the use of nanotechnologies in the food sector. [more]
[NanoBio-News-Archive]



Useful Links
Useful web resources concerning nanobiotechnology
[Links]